Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New urine test could spot bladder tumors more accurately

NCT ID NCT06072027

Diagnosis Sponsor: Institut Paoli-Calmettes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a new urine test called VISIOCYT can better detect bladder tumors than standard methods. Over 700 patients undergoing cystoscopy (a scope procedure) provided urine samples for both standard and VISIOCYT analysis. The goal was to see how accurate the new test is at ruling out cancer and catching it when present.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VISIOCYT bladder cytology test
What this could lead to
If successful, this test could offer a more accurate, non-invasive way to detect or monitor bladder tumors, potentially reducing the need for invasive procedures.
What could go wrong
This is a completed observational study, not a treatment trial. The test may not prove more accurate than standard cytology, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

701 people

The number who actually took part.

Started

Nov 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient to undergo cystoscopy for diagnosis (suspected bladder tumor) or follow-up of bladder tumor

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient over 18 years of age, * Signed consent to participate, * Affiliation with a social security scheme, or beneficiary of such a scheme, * Patient to undergo cystoscopy for diagnosis (suspected bladder tumor) or follow-up of bladder tumor Exclusion Criteria: * Patients managed or followed up for a bladder tumor of non-urothelial histology, * Renal transplant patients, * Patient having received pelvic radiotherapy, * Pregnant or potentially pregnant women (of childbearing age, without effective contraception) or nursing mothers, * Person in an emergency situation, adult under legal protection (guardianship, curatorship or safeguard of justice), or unable to express consent, * Inability to undergo medical follow-up for geographical, social or psychological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder cancer

Contacts and locations

Locations

  • Institut Paoli-Calmettes

    Marseille, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.